Giant Biogene Holding Co. Ltd., China’s largest supplier of collagen-based skincare products, has filed for a Hong Kong IPO, joining the growing list of Chinese companies seeking to tap into global capital through the financial hub as they shy away from increasingly problematic US listings.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
